It’s Raining EUAs: US FDA Drops Slew Of EUAs In Response To COVID-19
While US regulators have ramped up the number of authorizations they’ve granted to companies on an emergency basis in response to the COVID-19 crisis, they really kicked things into high gear in just the past few days. On 10 April the agency issued a record number of EUAs in response to the pandemic.
You may also be interested in...
After CDC concerns about the quality of Chinese-manufactured respirators, the US FDA has pulled a number of products from its list of authorized respirators for health care providers. The agency said the remaining authorized respirators made in China are no longer eligible for use after being decontaminated due to concerns about their ability to hold up after decontamination.
Medtech insiders offer 10 strategies for medtech companies to rethink their businesses right now.
The head of the largest medical device lobby group told reporters the industry hopes to get 25 million diagnostic tests produced by the end of the month to fight the ongoing coronavirus pandemic in the US.